The global Aminoglycosides Antibiotics market size is predicted to grow from US$ 717 million in 2025 to US$ 666 million in 2031; it is expected to grow at a CAGR of -1.2% from 2025 to 2031.
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.
The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.
In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.
LP Information, Inc. (LPI) ' newest research report, the “Aminoglycosides Antibiotics Industry Forecast” looks at past sales and reviews total world Aminoglycosides Antibiotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Aminoglycosides Antibiotics sales for 2025 through 2031. With Aminoglycosides Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminoglycosides Antibiotics industry.
This Insight Report provides a comprehensive analysis of the global Aminoglycosides Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminoglycosides Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aminoglycosides Antibiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminoglycosides Antibiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminoglycosides Antibiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides Antibiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aminoglycosides Antibiotics market?
What factors are driving Aminoglycosides Antibiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminoglycosides Antibiotics market opportunities vary by end market size?
How does Aminoglycosides Antibiotics break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook